Athenex provides second quarter 2022 financial results and business update

Buffalo, n.y., july 28, 2022 (globe newswire) -- athenex, inc. (nasdaq: atnx), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today provided a corporate and financial update for the second quarter ended june 30, 2022.
ATNX Ratings Summary
ATNX Quant Ranking